NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Stability of Formulations Contained in the Pharmaceutical Payload Aboard Space MissionsEfficacious pharmaceuticals with adequate shelf life are essential for successful space medical operations in support of space exploration missions. Physical and environmental factors unique to space missions such as vibration, G forces and ionizing radiation may adversely affect stability of pharmaceuticals intended for standard care of astronauts aboard space missions. Stable pharmaceuticals, therefore, are of paramount importance for assuring health and wellness of astronauts in space. Preliminary examination of stability of formulations from Shuttle and International Space Station (ISS) medical kits revealed that some of these medications showed physical and chemical degradation after flight raising concern of reduced therapeutic effectiveness with these medications in space. A research payload experiment was conducted with a select set of formulations stowed aboard a shuttle flight and on ISS. The payload consisted of four identical pharmaceutical kits containing 31 medications in different dosage forms that were transported to the International Space Station (ISS) aboard the Space Shuttle, STS 121. One of the four kits was stored on the shuttle and the other three were stored on the ISS for return to Earth at six months intervals on a pre-designated Shuttle flight for each kit; the shuttle kit was returned to Earth on the same flight. Standard stability indicating physical and chemical parameters were measured for all pharmaceuticals returned from the shuttle and from the first ISS increment payload along with ground-based matching controls. Results were compared between shuttle, ISS and ground controls. Evaluation of data from the three paradigms indicates that some of the formulations exhibited significant degradation in space compared to respective ground controls; a few formulations were unstable both on the ground and in space. An increase in the number of pharmaceuticals from ISS failing USP standards was noticed compared to those from the shuttle flight. A comprehensive evaluation of results is in progress.
Document ID
20080014099
Acquisition Source
Johnson Space Center
Document Type
Conference Paper
Authors
Putcha, Lakshmi
(NASA Johnson Space Center Houston, TX, United States)
Du, Brian
(NASA Goddard Space Flight Center Greenbelt, MD, United States)
Daniels, Vernie
(NASA Goddard Space Flight Center Greenbelt, MD, United States)
Boyd, Jason L.
(NASA Goddard Space Flight Center Greenbelt, MD, United States)
Crady, Camille
(NASA Goddard Space Flight Center Greenbelt, MD, United States)
Satterfield, Rick
(NASA Goddard Space Flight Center Greenbelt, MD, United States)
Date Acquired
August 24, 2013
Publication Date
January 1, 2008
Subject Category
Aerospace Medicine
Meeting Information
Meeting: Life in Space for Life on Earth Symposium
Location: Angers
Country: France
Start Date: June 22, 2008
End Date: June 27, 2008
Distribution Limits
Public
Copyright
Work of the US Gov. Public Use Permitted.

Available Downloads

There are no available downloads for this record.
No Preview Available